Management of Graves disease: a review

HB Burch, DS Cooper - Jama, 2015 - jamanetwork.com
Importance Graves disease is the most common cause of persistent hyperthyroidism in
adults. Approximately 3% of women and 0.5% of men will develop Graves disease during …

Graves' disease

TJ Smith, L Hegedüs - New England Journal of Medicine, 2016 - Mass Medical Soc
Graves’ Disease | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy

A Antonelli, P Fallahi, G Elia, F Ragusa… - Best Practice & …, 2020 - Elsevier
Graves' disease (GD) is characterized by thyrotoxicosis, caused by the presence of
circulating thyroid stimulating antibodies (TSAb), that are determinant also in the …

Mortality in patients with permanent hypoparathyroidism after total thyroidectomy

M Almquist, K Ivarsson, E Nordenström… - Journal of British …, 2018 - academic.oup.com
Background Permanent hypoparathyroidism remains the most common adverse outcome
after total thyroidectomy, but long-term effects of hypoparathyroidism are unknown. The aim …

[PDF][PDF] Post-thyroidectomy hypocalcemia-risk factors and management

DN Pãduraru, D Ion, M Carsote, O Andronic… - …, 2019 - revistachirurgia.ro
The complications of thyroidectomy vary from hypocalcemia and recurrent laryngeal nerve
lesions to injury of vocal folds, local hematoma, cysts, granuloma. Post-operative …

Thyroid surgery for Graves' disease and Graves' ophthalmopathy

ZW Liu, L Masterson, B Fish, P Jani… - Cochrane Database …, 2015 - cochranelibrary.com
Background Graves' disease is an autoimmune disease caused by the production of auto‐
antibodies against the thyroid‐stimulating hormone receptor, which stimulates follicular cell …

Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid …

N Slijepcevic, V Zivaljevic, J Marinkovic, S Sipetic… - BMC cancer, 2015 - Springer
Background The aim of our study was to investigate the incidence of papillary thyroid
microcarcinoma (PTMC) in patients operated for benign thyroid diseases (BTD) and its …

Precision medicine in graves' disease and ophthalmopathy

G Elia, P Fallahi, F Ragusa, SR Paparo… - Frontiers in …, 2021 - frontiersin.org
Graves' disease (GD) is a condition caused by an autoimmune process involving the thyroid
gland, whose main outcome is hyperthyroidism. TSAb start the autoimmune process …

Considerations for thyroidectomy as treatment for Graves disease

M Smithson, A Asban, J Miller… - Clinical Medicine …, 2019 - journals.sagepub.com
Hyperthyroidism is a clinical state that results from abnormally elevated thyroid hormones.
Thyroid gland affects many organ systems; therefore, patients usually present with multiple …

Use of quality assessment tools in systematic reviews was varied and inconsistent

J Seehra, N Pandis, D Koletsi, PS Fleming - Journal of clinical …, 2016 - Elsevier
Objectives To assess the use of quality assessment tools among a cross-section of
systematic reviews (SRs) and to further evaluate whether quality was used as a parameter in …